This SuperSeries is composed of the SubSeries listed below.
Overall design: Refer to individual Series
| Accession | PRJNA292774; GEO: GSE72031 |
| Type | Umbrella project |
| Publications | Zhang T et al., "Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors.", Nat Chem Biol, 2016 Oct;12(10):876-84 |
| Submission | Registration date: 13-Aug-2015
Young Lab, Whitehead Institute for Biomedical Research |
| Relevance | Superseries |
Project Data:
| Resource Name | Number
of Links |
|---|
| Sequence data |
| SRA Experiments | 7 |
| Publications |
| PubMed | 1 |
| PMC | 1 |
| Other datasets |
| BioSample | 7 |
| GEO DataSets | 3 |
GEO Data Details| Parameter | Value |
|---|
| Data volume, Spots | 989880 |
| Data volume, Processed Mbytes | 36 |
| Data volume, Supplementary Mbytes | 450 |
| Parameter | Value |
|---|
| Data volume, Gbases | 16 |
| Data volume, Mbytes | 9575 |
Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors encompasses the following 2 sub-projects:
| Project Type | Number of Projects |
| Epigenomics | 1 |
BioProject
accession | Organism | Title |
|---|
| PRJNA292779 | Homo sapiens | Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors [ChIP-Seq] (Young Lab, Whitehead Institute...) |
|
| Transcriptome or Gene expression | 1 |
BioProject
accession | Organism | Title |
|---|
| PRJNA292780 | Homo sapiens | Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors [Affymetrix] (Young Lab, Whitehead Institute...) |
|